Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Blue Bird BLBD Stock Reversal Setup Slight Rise 20260420 Is Accuray ARAY stock worth entering at this stage Edges Higher 20260420 American Tower Corporation AMT Outperforms Broader Market Rally Ahead of Q1 2026 Earnings Release REBN Reborn Coffee Q1 2025 earnings show 76 percent year over year revenue gain shares fall 562 percent today Southeast Asias Biofuel Push May Strain Food Supplies and Export Capacities Social Security Timing Claim at 62 or Wait for Survivor Benefits at 67 NuScale Power vs Nano Nuclear Energy Comparing Commercial Milestones in NextGen Nuclear Bitcoin Price on May 27 2026 Cautious Trading Continues Amid Macro Uncertainty Qualcomm Surges as Investors Anticipate AI Device Boom SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Dips GLXY Q1 2026 Earnings EPS Misses Estimates Amid Crypto Market Volatility FactSet Q1 2026 Earnings EPS Beat Drives Positive Market Response UTSI Q4 2019 Earnings EPS Misses Estimates by Wide Margin CEVA Q1 2026 Earnings EPS Surprises by 122 Amid Strong Licensing Momentum CAPS Q1 2026 Earnings EPS Misses Estimates as Losses Widen on Operational Challenges IPHA Q1 2026 Earnings WiderThanExpected Losses on Zero Revenue FCNCN Preferred Shares Edge Higher Modest Gains Amidst Steady Trading Xsolla SPAC 1 Units XSLLU Holds Steady at 998 Neutral Stance Ahead of Catalysts Klaviyo KVYO Rallies 373 Toward Resistance Key Levels in Focus Korro Bio Inc KRRO Surges 62 as Biotech Stock Tests Key Resistance at 1295 Ivanhoe Electric IE Slips 294 as Key Support Levels Come into Focus MSC Income Fund Inc MSIF Gains Traction Approaches Key Resistance at 1271 COOTW Warrants Trade Near Penny Territory Shedding 35 Amid Thin Activity Codere Online CDRO Edges Lower Amidst Consolidation Key Levels in Focus XOMAP Holds Steady at 2543 as Preferred Stock Maintains Parity Southern Company Preferred SOJD Holds Steady Support Levels in Focus Atea Pharmaceuticals AVIR Gains 425 as Stock Tests Key Resistance Level